Search

The Netherlands: Inauguration Ceremony Halix Opens New Facility for the Development and Manufacturing of Biopharmaceuticals

| Editor: Alexander Stark

With an official inauguration ceremony, Halix celebrated the opening of its brand-new 6700 m2 cGMP facility at the Leiden Bio Science Park.

Related Company

Halix celebrated the official inauguration ceremony of a new facility for the development and manufacturing of biopharmaceuticals.
Halix celebrated the official inauguration ceremony of a new facility for the development and manufacturing of biopharmaceuticals.
(Source: Halix)

Leiden/The Netherlands — Epidemics and pandemics have changed historical life and, as a result of climate change, will transform future life in modern economies. Nowadays, the Chikungunya virus and Zika virus, carried via mosquitoes, are already prevalent in Africa and South America. Halix produces vaccines to prevent spreading those infectious and other viral diseases. The company is also focusing on therapeutic vaccines, specific oncolytic therapeutic vaccines such as to cure dedicated types of cancer.

The opening of a new cGMP facility in Leiden enables Halix to support its clients’ manufacturing of protein-based products, the key technology for future drug production, and virus-based products with cutting-edge technologies. The new building houses GMP production areas for viral and protein products and client-specific technologies, as well as associated laboratory and administration areas.

The new five-level production facility contains a state-of-the-art manufacturing line for viral vaccines and viral vectors, starting soon, with a 250 L bioreactor scale. A separate protein manufacturing area with a capacity up to 1000 L single-use bioreactors is available. Laboratory spaces within the facility enable process development and transfer, analytical development and quality control of biopharmaceuticals.

Ensuring highest quality standards and GMP compliant production, the facility is designed and equipped according to latest biopharmaceutical quality standards. All BSL2 cleanrooms are structured according to the unidirectional process flow of personal and materials and prepared for an upgrade to BSL3, if required. The office spaces, laboratory and cleanroom areas offer up to 70 employees attractive and modern workplaces.

(ID:46255199)